Dr. Suman Meyur

Dr. Suman Meyur

Consultant Oncologist ยท MBBS, MD, FRSPH (UK), FICM, PDCR
ESMO ASCO RSPH AROI Harvard Med School NIH/NIDA GCP
15+ Years Experience
14+ Publications
4 Hospital Affiliations
๐Ÿ“ž +91 96744 57101 WhatsApp
โœ‰ sumanmeyur@yahoo.co.in
๐Ÿ“ Kolkata, West Bengal
๐Ÿ—“ Consultation Schedule
Saroj Gupta Cancer Centre & Research Institute Thakurpukur, Kolkata
๐Ÿ“ž 033-2467-8002
Wed & Fri 1:00 PM
Manipal Hospitals (prev. AMRI) Dhakuria, Kolkata
๐Ÿ“ž +919038705205
Thursday 4:00 PM Prior appointment
Ruby Cancer Centre Kolkata
๐Ÿ“ž +918336990451
Tuesday 5:30 PM Prior appointment
Narayan Memorial Hospital Kolkata
๐Ÿ“ž +91629195058
Sunday 10:00 AM
Request an Appointment โ†’

About Me

Oncology with Precision & Compassion

Dr. Suman Meyur is a consultant oncologist with an MD in Radiation Oncology (First Class) from IPGMER & SSKM Hospital, West Bengal University of Health Sciences, and an MBBS (First Class) from Calcutta National Medical College. He is currently Deputy-in-Charge of Medical Oncology at Saroj Gupta Cancer Centre & Research Institute (SGCCRI), Thakurpukur, and a Specialist Consultant at Manipal Dhakuria and Ruby Cancer Centre

A Visiting Faculty for Biostatistics and Advanced Epidemiology at NSHM Knowledge Campus under MAKAUT, Dr. Meyur blends academic rigour with frontline clinical practice across multiple centres in the city. He is a regular speaker at national and international oncology conferences, including the AROI All India Conference, Indian Medical Association, and Indian Railway Medical Service Association.

Certified by Harvard Medical School (2024), Stanford University (2016 & 2025), and the NIH/NIDA (2024), he carries internationally recognised credentials in oncology, clinical research, and evidence-based medicine. He is also a peer reviewer for Elsevier and CG Publishing (University of Illinois) journals.

โœฆ
Qualifications
MBBS (First Class), Calcutta National Medical College  ยท  MD Radiation Oncology (First Class), IPGMER & SSKM Hospital, WBUHS
โœฆ
Current Hospital Positions
Deputy-in-Charge, Medical Oncology โ€” SGCCRI, Thakurpukur  ยท  Visiting Consultant โ€” Ruby General Hospital & Cancer Center  ยท  Consultant Clinical Oncology โ€” Narayan Memorial Hospital
โœฆ
Fellowship & Academic Role
Fellowship in Intensive Care Medicine โ€” Medvarsity, Apollo Hospitals, Hyderabad (2020โ€“21)  ยท  Visiting Faculty, Biostatistics & Advanced Epidemiology โ€” NSHM Knowledge Campus under MAKAUT
โœฆ
Selected Speaker Engagements
'Optimizing Treatment in Recurrent/Metastatic Head & Neck Cancer' โ€” AROI All India Conference, 2025  ยท  'Management of Her2 Positive Breast Cancer' โ€” IMA Behala, 2025  ยท  'Continuum of Care in Breast Cancer' โ€” Indian Railway Medical Service Association, 2025

Dr. Suman Meyur in conversation on advances in oncology treatment.
Replace this with your own YouTube video link.

Quick Facts
โ–ธ 360 degree oncology solution- Tumour Board, Decision and Implementation
โ–ธ Physician with humanitarian core
โ–ธ Academician- Precision Oncology, Public Health and Health Economy
โ–ธ Peer Reviewer โ€” Elsevier & CG Publishing (Univ. of Illinois)

Specializations

Areas of Clinical Expertise

01
Head & Neck Oncology

Hypofractionated palliative radiotherapy, concurrent chemoradiation, and management of oral, pharyngeal, laryngeal, and nasopharyngeal malignancies โ€” backed by original peer-reviewed research.

02
Breast Oncology

Post-mastectomy hypofractionated radiation, HER2-targeted therapy, and comprehensive care from early-stage to metastatic breast cancer. Led prospective randomised dosimetric trials.

03
Gastrointestinal Cancers

Single-centre prospective study experience in GI stromal tumours; systemic and radiation management of colorectal, pancreatic, and hepatobiliary cancers.

04
Prostate & Urological Cancers

Real-world evidence-based management of metastatic hormone-sensitive prostate cancer including triplet therapy โ€” co-authored in a landmark multicentre Indian study (2024).

05
Palliative & Supportive Care

Certified under the National Programme for Palliative Care (Govt. of West Bengal). Research focus on quality-adjusted survival and palliative intent radiotherapy for Stage IV disease.

06
Clinical Research & Trials

Co-PI in a Phase II Tipiracil/Trifluridine trial; peer reviewer for Elsevier and CG Publishing. Proficient in IBM SPSS, STATA, RevMan, and Elekta ONCENTRA TPS.

Research

Publications & Certifications

Dr. Meyur has authored and co-authored over 14 peer-reviewed publications spanning radiation oncology, palliative care, GI oncology, breast cancer, and epidemiology.

Certifications

2025Stanford University School of Medicine โ€” Antibiotic Stewardship
2025Professional Diploma in Clinical Research
2024Harvard Medical School โ€” Advanced Management of Oncological Diseases
2024NIDA, NIH Maryland โ€” Good Clinical Practice Certification
2020National Programme for Palliative Care, Govt. of West Bengal
2019Image Guided Radiotherapy โ€” AMPI, Eastern Chapter
20185th AROI-ICRO INTAS Radiobiology Teaching Course
2017National PG Teaching Course on Hypofractionation โ€” 27th ICRO
2016Stanford University โ€” Statistics in Medicine

Triplet therapy in metastatic hormone-sensitive prostate cancer: A real-world Indian multicentre study.

Mondal D, Roy S, Bhattacharjee A, Roy R, Meyur S, Biswas B. 2024

Epidemiology, prognostication and treatment outcome of gastrointestinal stromal tumour: A single centre prospective study.

Biomedicine. Prasad N, Meyur S, Das SM, Paul S, Basu S, Das S. 2023

A pilot study on feasibility, toxicity and efficacy of novel hypofractionated radiation therapy in advanced non-nasopharyngeal head and neck carcinoma treated with palliative intent.

Palliative Medicine in Practice. Meyur S, Pal SK, Maiti S, Basu S. 2021

Dynamics of Decision-Making in Medical Pluralism: A Systematic Review of Conceptual Models.

Alternative Therapies in Health & Medicine. Chowdhuri PD, Kundu K, Meyur S. 2022

The incidence of hypothyroidism in patients of head and neck carcinoma treated with radiotherapy and added risk with chemotherapy.

Journal of Radiotherapy in Practice. Singh D, Roy N, Pal SK, Basu S, Meyur S. 2022

Comparison of conventional and hypofractionated radiation after mastectomy in locally advanced breast cancer: a prospective randomised study on dosimetric evaluation and treatment outcome.

Journal of Radiotherapy in Practice. Maiti S, Meyur S, Mandal BC, Shenoi LR, Biswas S, Basu S. 2021

Analysis of Volumetric Dosimetry of Target Volumes and Organs at Risk on ICRU Point Based Dose Planning in CT-Guided HDR Intracavitary Brachytherapy to Carcinoma Cervix.

Indian Journal of Gynecologic Oncology. Maiti S, Pal SK, Meyur S, Mandal BC, Roy SB, Basu S. 2019

A Study on Optimization of Dose Distribution by Altering Dose Prescription Points in Post-Mastectomy Hypofractionated Chest Wall Irradiation.

Biomedicine. Maiti S, Meyur S, Pal S, Sardar P, Mandal BC, Basu S. 2018

Does Treatment Choice Vary with Disease? An Analysis of Demographic Factors and Disease Burden.

IMPACT: International Journal of Research in Applied, Natural and Social Sciences. Chowdhuri PD, Meyur S. 2018

Exploration of Personality Factors and their Effects on People's Decision Making of Complementary and Alternative Medicine.

International Journal of Management Studies (Vol. 5, No. 2). Chowdhuri PD, Meyur S. 2018

Primary extra nodal lymphoma: A rare case of gnathic involvement.

International Journal of Current Research. Roy S, Chatterjee R, Kundu S, Meyur S, Gayen S. 2018

Role of primary care providers in dengue prevention and control in the community: practitioners' and laypersons' perspectives in Dhaka, Bangladesh.

International Journal of Integrated Care. Chowdhury PD, Haque CE, Meyur S. 2013

Comparison between Two Regimens of Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. [Poster Presentation]

Bengal Cancer Summit. Prasad N, Meyur S, Mirza B, Maiti S, Basu S. 2019

Memberships

Professional Affiliations

FRSPH
Fellow of the Royal Society for Public Health, UK
MN โ€“ 132201
AROI
Association of Radiation Oncologists of India
LM โ€“ 3001
ESMO
European Society of Medical Oncology
ID โ€“ 422743
ASCO
American Society of Clinical Oncology
ID โ€“ 710938

Blog

Insights & Updates

Sharing knowledge on cancer care, treatment advances, and patient guidance. Articles will be added here regularly.

๐Ÿงฌ
Medical Oncology
Understanding Triplet Therapy in Prostate Cancer: What Patients Need to Know
A plain-language explanation of the latest evidence on triplet therapy for hormone-sensitive prostate cancer and what it means for patients in India.
Coming Soon Read More โ†’
๐ŸŽ—
Breast Cancer
HER2-Positive Breast Cancer: New Horizons in Targeted Treatment
An overview of how modern HER2-directed therapies are transforming outcomes for patients with HER2-positive breast cancer.
Coming Soon Read More โ†’
๐Ÿ”ฌ
Head & Neck Cancers
Hypofractionated Radiotherapy in Advanced Head & Neck Cancer: A Patient's Guide
Demystifying hypofractionated palliative radiotherapy โ€” what it is, who it helps, and what to expect during treatment.
Coming Soon Read More โ†’
abp2
Anandabazar Patrika Interview 1
Nutrition during the time of CoVID 19 epidemic: A Public Health Initiative
abp1
Anandabazar Patrika Interview (Contd.)
Balanced Diet during the time of CoVID 19 epidemic: A Public Health Initiative
abp3
Anandabazar Patrika Interview 2
On Hepatitis Awareness: A Public Health Initiative

More Articles Coming Soon

Subscribe via the contact form below to receive updates when new posts are published.

Contact

Get in Touch

For consultations, second opinions, or general enquiries, reach out via phone, email, or the form. All messages are responded to within 24 hours.

โœ‰
Email
sumanmeyur@yahoo.co.in
๐Ÿ“ž
Phone
+91 96744 57101
Chat on WhatsApp
๐Ÿ“
Primary Base
SGCCRI, Thakurpukur, Kolkata, West Bengal
๐Ÿ—“
OPD Days
Tuesday ยท Wednesday ยท Thursday ยท Friday ยท Sunday

Send a Message

Dr. Meyur's team will get back to you shortly.

โœ“ Message sent successfully. Thank you.